COL1A1 peptides have been previously described to be associated with fibrosis‐related diseases, including heart failure, CKD and liver diseases, indicating that the degradation of the COL1 molecule is altered in fibrosis [9, 27, 28]. This evidence concerns the gene COL1A1 and chronic kidney disease.